Published in the Journal of Pain and Symptom
Management, the Study Highlights Significant Advancements Using the
ePAL App, now known as mytuesday, to Reduce Symptom Severity and
Hospital Admissions
NASHVILLE, Tenn., Aug. 6, 2024
/PRNewswire/ -- Tuesday Health is thrilled to announce the
publication of groundbreaking results from the ePAL randomized
controlled trial, highlighting significant advancements in
continuous monitoring for patients with serious illness. The study,
published in the Journal of Pain and Symptom
Management, showcases the efficacy of ePAL, a smartphone
application leveraging patient-reported outcomes and artificial
intelligence to optimize cancer pain management. Patients who
received the ePAL app had significant improvements in pain and a
marked 69% reduction in pain-related hospitalizations.
ePAL study shows 26% pain reduction and 69%
fewer hospitalizations with the ePal, now mytuesday, app.
The ePAL study is a first-of-its-kind randomized controlled
trial demonstrating that a digital continuous monitoring solution
can reduce symptom burden and significantly reduce hospitalizations
in patients with serious illness. The app, initially developed at
the Mass General Brigham healthcare system, has been acquired and
expanded by Tuesday Health as the "mytuesday" app, which
comprehensively addresses the multitude of pain and non-pain
symptoms that impact the quality of life and drive unwanted
healthcare utilization in patients with all forms of serious
illness.
The ePAL study enrolled 112 patients with pain from metastatic
solid tumors, randomly assigning them to either a control group or
an intervention group using ePAL for eight weeks. Both groups
received usual oncologic and palliative care. Key findings
include:
- Significant Reduction in Pain Severity: Patients
using ePAL reported a significant 26% reduction in pain
severity.
- Improved Attitudes Toward Cancer Pain Management: Users of the
app reported feeling significantly more empowered to manage their
cancer pain.
- Reduced Hospital Admissions: ePAL users had a 69%
reduction in pain-related admissions and an 82% reduction in
pain-related admissions through the emergency department.
"We are excited to share the results of this landmark randomized
controlled study, which underscore the transformative potential of
technology in enhancing serious illness care," said Dr.
Mihir Kamdar, lead author and Head
of Clinical Delivery at Tuesday Health. "The significant reductions
in symptom burden and hospital admissions highlight how integrating
AI and continuous monitoring can help patients get the care they
need in real-time. We look forward to continuing this journey by
bringing our comprehensive 'mytuesday' digital supportive care
solution to a broader population of seriously ill patients."
"Patients with serious illness struggle to find the symptom help
they need at home and routinely end up in the ED or hospital," said
Dr. Jacob Strand, Chair of
Enterprise Center for Palliative Medicine at Mayo Clinic, study
co-author, and clinical advisory board member of Tuesday Health.
"The ePAL study demonstrates the promise of how a comprehensive
continuous monitoring solution, like mytuesday, can create a
digital safety net for patients with serious illness." The findings
from the ePAL study pave the way for broader dissemination and
implementation of the "mytuesday" app, particularly in settings
with limited access to palliative care.
Jim Wieland, CEO of Tuesday
Health, expressed his enthusiasm about the study's implications for
patient care. "This study reaffirms our commitment to innovative,
value-based care models that prioritize patient outcomes. The
acquisition of ePAL and its expansion to the 'mytuesday' platform
represents a significant step forward in our mission to transform
the management of serious illnesses and improve the quality of life
for patients and their families."
Tuesday Health remains dedicated to leveraging cutting-edge
technology and evidence-based protocols to enhance patient care and
support. For more information about the study and the "mytuesday"
app, please visit www.TuesdayHealth.com
About Tuesday Health:
Tuesday Health is a value-based
supportive care organization that delivers patient-directed,
whole-person care and support for seriously ill patients and their
caregivers. The company is dedicated to transforming supportive
care through clinical expertise, industry-leading data, and
technology. Launched in 2023, Tuesday Health was developed from a
partnership of Valtruis and Mass General Brigham Ventures.
Media Contact
Kelli
Campbell
Tuesday Health Communications
kcampbell@tuesdayhealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tuesday-health-unveils-groundbreaking-results-from-the-epal-continuous-monitoring-study-302214773.html
SOURCE Tuesday Health